Table 3.

FDA Approved antimicrobial nanomedicine.

Name	Active Ingredient	Bacteria/ Infection	Company
Arikayce®	Amikacin	Mycobacterium avium complex (MAC) lung infection	Insmed Inc.
ArikaceTM	Amikacin	P. aeruginosa, Cystic Fibrosis	Transave Inc.
LipoquinTM (fast release) and PulmaquinTM (slow release)	Ciprofloxacin	Non-cystic fibrosis bronchiectasis (P. aeruginosa)	Aradigm
CAF01	Subunit protein antigen Ag85B-ESAT, DDA, TDB	Tuberculosis	Statens Serum Institute
ALIS	Amikacin	Nontuberculous Mycobacterial Lung infection	Insmed Inc.